Horizon Technology Finance
VC Fund
Farmington, United States
Horizon Technology Finance is a VC fund in Farmington focused on Health Care and Biotechnology. Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billion in venture loans to thousands of companies. The company was founded in 2003 and is headquartered in Farmington, Connecticut.
- Total investments:
- 113
- Last investment:
- Lead investor:
- 71%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Horizon Technology Finance invests in
Stages Horizon Technology Finance invests in
Countries Horizon Technology Finance invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 8 contacts → | |||
Round size
- Post-IPO Debt
- $10M–$40M
- Debt Financing
- $5M–$30M
- Venture - Series Unknown
- $6.5M–$45M
Investment Focus
Industry
- Health Care 41 (36%)
- Biotechnology 34 (30%)
- Medical Device 22 (19%)
- Software 15 (13%)
- Medical 13 (12%)
Stage
- Debt Financing 81 (72%)
- Post-IPO Debt 15 (13%)
- Venture - Series Unknown 4 (4%)
- Series C 3 (3%)
- Private Equity 2 (2%)
Country
- United States 97 (86%)
- Canada 3 (3%)
- India 2 (2%)
- France 1 (1%)
- Ireland 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Apostolos Apostolakis
Chief Credit Officer
|
Chief Credit Officer | Total investments: 45 | Find email | |
Bryce Bewley
Venture Debt
|
Venture Debt | Total investments: 0 | Find email | |
Daniel Devorsetz
Senior Vice President and Chief Investment Officer
|
Senior Vice President and Chief Investment Officer | Total investments: 1 | Find email | |
Diane Earle
Chief Credit Officer
|
Chief Credit Officer | Total investments: 0 | Find email | |
Gary Moro
Vice President
|
Vice President | Total investments: 0 | Find email | |
| See all 8 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bioness is the provider of innovative technologies helping people regain mobility and independence. | $10M / Debt Financing / Sep 02, 2026 | ||
| Stellar Cyber greatly reduces enterprise risk by the early and precise identification and remediation of all attack activities while slashing costs, retaining investments in existing tools and accelerating analyst productivity. The platform also provides effortless deployment of sensors to fill any gap on premise or in the cloud. | $25M / Debt Financing / Apr 16, 2026 | ||
| Hyperfine makes MRI accessible to every patient regardless of income or resources. | $40M / Post-IPO Debt / Mar 19, 2026 | ||
| OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now. | $40M / Debt Financing / Feb 11, 2026 | ||
| Pelthos Therapeutics is a biotechnology firm specializing in life sciences of therapeutics and flavours. | $30M / Post-IPO Debt / Jan 13, 2026 | ||
| Kodiak Robotics develops autonomous technology for long-haul trucking. It specializes in the fields of autonomous vehicles, information technology, software, logistics, and robotics. It was founded in 2018 and headquartered in Mountain View, California. | $30M / Post-IPO Debt / Dec 31, 2025 | ||
| Samba TV provides streaming services, connected devices, time-shifting, and multi-screen viewership, our data products solve real problems and create a meaningful competitive advantage for our clients given the dramatic growth in streaming services, connected devices, time-shifting, and multi-screen viewership. | $30M / Debt Financing / Dec 08, 2025 | ||
| SparkCharge is an automotive company that manufactures and develops charging stations for electric vehicles. The company's product offerings include mobile battery charging units, off-grid power hubs, and permanent EV infrastructure solutions. These services cater to a diverse clientele, including fleets, delivery services, events, autooriginal equipment manufacturers (OEMs), ports, transportation sectors, autonomous vehicles, and rideshare companies. By providing rapid deployment and flexible service levels, SparkCharge aims to eliminate common barriers to EV adoption, such as infrastructure costs and deployment delays. | $15M / Debt Financing / May 20, 2025 | ||
| Onkos Surgical is a privately-held surgical oncology company that brings new technology and solutions to surgical oncologists. There are huge opportunities for innovation where the complexity of the disease state requires more diverse solutions. Onkos Surgical will be 100% focused on bringing new technology and solutions to surgical oncologists whoserve a population of which a large portion of the patients are children and the broader population may require personalized solutions. | $30M / Debt Financing / Jan 08, 2025 | ||
| Finexio is a smart B2B payment network. The Finexio network eliminates commercial paper check spend by identifying and routing payments through a unique “network of closed loop networks”. Payments on the Finexio rails are seamlessly pushed into a supplier’s bank accounts at fees substantially lower than prevailing commercial payment costs.Finexio integrates into large payment aggregators, accounts payable automation, and procurement software platforms to enable them with a more efficient payment modality. | $10M / Debt Financing / Dec 17, 2024 | ||
| See all 113 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Horizon Technology Finance invest in?
Horizon Technology Finance invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Debt Financing and Post-IPO Debt stage. Most of the 113 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Horizon Technology Finance invest in?
Horizon Technology Finance typically joins rounds of $10M–$40M at Post-IPO Debt, $5M–$30M at Debt Financing and $6.5M–$45M at Venture - Series Unknown. These are whole funding-round sizes, not Horizon Technology Finance's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Horizon Technology Finance took part in.
How do I contact Horizon Technology Finance?
Public channels for Horizon Technology Finance include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Horizon Technology Finance?
The team at Horizon Technology Finance includes Apostolos Apostolakis (Chief Credit Officer), Bryce Bewley (Venture Debt) and Daniel Devorsetz (Senior Vice President and Chief Investment Officer), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
